Thornburg Investment Management Inc Biomarin Pharmaceutical Inc Transaction History
Thornburg Investment Management Inc
- $7.17 Billion
- Q3 2024
A detailed history of Thornburg Investment Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Thornburg Investment Management Inc holds 96,907 shares of BMRN stock, worth $6.06 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
96,907
Previous 161,446
39.98%
Holding current value
$6.06 Million
Previous $13.3 Million
48.75%
% of portfolio
0.1%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
639Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.42 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.21 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.18 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$869 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$656 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...